{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:02:23Z","timestamp":1789556543803,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":209,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.SBMU.RETECH.REC.1400.1083"],"award-info":[{"award-number":["IR.SBMU.RETECH.REC.1400.1083"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.SBMU.RETECH.REC.1400.1113"],"award-info":[{"award-number":["IR.SBMU.RETECH.REC.1400.1113"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["CRD42024499140"],"award-info":[{"award-number":["CRD42024499140"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.prdoa.2025.100381","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:52:54Z","timestamp":1753919574000},"page":"100381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The impact of pregabalin and gabapentin on essential tremor: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"13","author":[{"given":"Hooman","family":"Pourbala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhale","family":"Nahavandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Maghsoudlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina Gazerani","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avin","family":"Khallaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Izadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Faizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6915-6028","authenticated-orcid":false,"given":"Hadi","family":"Esmaily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prdoa.2025.100381_b0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.27121","article-title":"Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society","volume":"33","author":"Bhatia","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2025.100381_b0010","article-title":"Essential tremor: diagnosis and management","volume":"366","author":"Shanker","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.prdoa.2025.100381_b0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1152\/jn.00398.2022","article-title":"Essential Tremor accentuates the pattern of tremor-band coherence between upper-limb muscles","volume":"129","author":"Free","year":"2023","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.prdoa.2025.100381_b0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5334\/tohm.632","article-title":"How common is essential tremor? Update on the worldwide prevalence of essential tremor","volume":"11","author":"Louis","year":"2021","journal-title":"Tremor Other Hyperkinet. Mov. (N. Y.)"},{"key":"10.1016\/j.prdoa.2025.100381_b0025","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJMcp1707928","article-title":"Essential tremor","volume":"378","author":"Haubenberger","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 3","key":"10.1016\/j.prdoa.2025.100381_b0030","first-page":"55","article-title":"Epidemiology and genetics of essential tremor","volume":"13","author":"Brin","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2025.100381_b0035","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/mds.26582","article-title":"Linkage of familial essential tremor to chromosome 5q35: linkage of familial essential tremor to chromosome 5","volume":"31","author":"Hicks","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2025.100381_b0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/WCO.0b013e3281e66942","article-title":"Update on pathogenesis and treatment of essential tremor","volume":"20","author":"Lorenz","year":"2007","journal-title":"Curr. Opin. Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.prdoa.2025.100381_b0045","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.parkreldis.2017.07.014","article-title":"The etiology of essential tremor: genes versus environment","volume":"46","author":"Hopfner","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.prdoa.2025.100381_b0050","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1212\/01.wnl.0000310425.76205.02","article-title":"Pathologic findings in prospectively ascertained essential tremor subjects","volume":"70","author":"Shill","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.prdoa.2025.100381_b0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12311-015-0735-z","article-title":"Linking essential tremor to the cerebellum: neurochemical evidence","volume":"15","author":"Marin-Lahoz","year":"2016","journal-title":"Cerebellum"},{"key":"10.1016\/j.prdoa.2025.100381_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/biom11121813","article-title":"The pathophysiology and treatment of essential tremor: the role of adenosine and dopamine receptors in animal models","volume":"11","author":"Kosmowska","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.prdoa.2025.100381_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103247","article-title":"Multimodal imaging of essential tremor and dystonic tremor","volume":"36","author":"B\u00e9dard","year":"2022","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.prdoa.2025.100381_b0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5334\/tohm.229","article-title":"The GABA hypothesis in essential tremor: lights and shadows","volume":"4","author":"Gironell","year":"2014","journal-title":"Tremor Other Hyperkinet. Mov. (N Y)"},{"key":"10.1016\/j.prdoa.2025.100381_b0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.medcli.2023.12.013","article-title":"Essential tremor: update of therapeutic strategies","volume":"162","author":"Gironell","year":"2024","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.prdoa.2025.100381_b0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2147\/NDT.S4795","article-title":"Overview of essential tremor","volume":"6","author":"Zesiewicz","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.prdoa.2025.100381_b0085","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/(SICI)1097-4598(200005)23:5<771::AID-MUS15>3.0.CO;2-9","article-title":"Strength training can improve steadiness in persons with essential tremor","volume":"23","author":"Bilodeau","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.prdoa.2025.100381_b0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/00222895.2015.1028583","article-title":"Resistance training reduces force tremor and improves manual dexterity in older individuals with essential tremor","volume":"48","author":"Kavanagh","year":"2016","journal-title":"J. Mot. Behav."},{"key":"10.1016\/j.prdoa.2025.100381_b0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ctcp.2018.10.010","article-title":"Yoga led by a physical therapist for individuals with essential tremor: an explorative pilot study","volume":"34","author":"Vance","year":"2019","journal-title":"Complement. Ther. Clin. Pract."},{"key":"10.1016\/j.prdoa.2025.100381_b0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1756285609104791","article-title":"Diagnosis and management of essential tremor and dystonic tremor","volume":"2","author":"Gironell","year":"2009","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.prdoa.2025.100381_b0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11940-013-0239-4","article-title":"Update on treatment of essential tremor","volume":"15","author":"Zesiewicz","year":"2013","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.prdoa.2025.100381_b0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.5603\/PJNNS.a2020.0079","article-title":"Botulinum toxin type a for hand tremor: a meta-analysis of randomised controlled trials","volume":"54","author":"Zheng","year":"2020","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.prdoa.2025.100381_b0115","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s13311-020-00899-2","article-title":"Managing essential tremor","volume":"17","author":"Hopfner","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.prdoa.2025.100381_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14030203","article-title":"Botulinum toxin for essential tremor and hands tremor in the neurological diseases: a meta-analysis of randomized controlled trials","volume":"14","author":"Liao","year":"2022","journal-title":"Toxins (basel)"},{"key":"10.1016\/j.prdoa.2025.100381_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2024.1319520","article-title":"Cognitive outcomes in patients with essential tremor treated with deep brain stimulation: a systematic review","volume":"18","author":"Al Ali","year":"2024","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.prdoa.2025.100381_b0130","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurol.2016.07.014","article-title":"Essential tremor: Update of therapeutic strategies (medical treatment and gamma knife thalamotomy)","volume":"172","author":"Witjas","year":"2016","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.prdoa.2025.100381_b0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.mcna.2018.10.016","article-title":"Essential tremor","volume":"103","author":"Reich","year":"2019","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.prdoa.2025.100381_b0140","first-page":"71","article-title":"A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice","volume":"14","author":"Tzellos","year":"2010","journal-title":"Hippokratia"},{"key":"10.1016\/j.prdoa.2025.100381_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119223","article-title":"Current drug development overview: targeting voltage-gated calcium channels for the treatment of pain","volume":"24","author":"Antunes","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prdoa.2025.100381_b0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.parkreldis.2017.11.345","article-title":"Increased glutamate+ glutamine levels in the thalamus of patients with essential tremor: a preliminary proton MR spectroscopic study","volume":"47","author":"Barbagallo","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.prdoa.2025.100381_b0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s40478-014-0157-z","article-title":"Decreased EAAT2 protein expression in the essential tremor cerebellar cortex","volume":"2","author":"Lee","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.prdoa.2025.100381_b0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40673-020-00116-y","article-title":"A pilot study of essential tremor: cerebellar GABA+\/Glx ratio is correlated with tremor severity","volume":"7","author":"Tapper","year":"2020","journal-title":"Cerebellum Ataxias"},{"key":"10.1016\/j.prdoa.2025.100381_b0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2019.12.045","article-title":"Inhibition of excessive glutamatergic transmission in the ventral thalamic nuclei by a selective adenosine A1 receptor agonist, 5'-chloro-5'-deoxy-(\u00b1)-ENBA underlies its tremorolytic effect in the harmaline-induced model of essential tremor","volume":"429","author":"Kosmowska","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.prdoa.2025.100381_b0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/mdc3.12927","article-title":"A pilot double-blind randomized trial of perampanel for essential tremor","volume":"7","author":"Handforth","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.prdoa.2025.100381_b0175","doi-asserted-by":"crossref","unstructured":"L. Magnus, Nonepileptic uses of gabapentin, Epilepsia 40(Suppl 6) (1999) S66\u2013S72; discussion S73-4, https:\/\/doi.org\/10.1111\/j.1528-1157.1999.tb00936.x.","DOI":"10.1111\/j.1528-1157.1999.tb00936.x"},{"key":"10.1016\/j.prdoa.2025.100381_b0180","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/106002800303700222","article-title":"Gabapentin for the treatment of tremor","volume":"37","author":"Faulkner","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.prdoa.2025.100381_b0185","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00007611-199808000-00007","article-title":"Gabapentin for treatment of pain and tremor: a large case series","volume":"91","author":"Merren","year":"1998","journal-title":"South. Med. J."},{"key":"10.1016\/j.prdoa.2025.100381_b0190","article-title":"Pregabalin for essential tremor","volume":"10","author":"Bruno","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.prdoa.2025.100381_b0195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cpdd.446","article-title":"Gabapentin and pregabalin for the treatment of anxiety disorders","volume":"7","author":"Greenblatt","year":"2018","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.prdoa.2025.100381_b0200","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2174\/1570159X18666200124145743","article-title":"Current and future neuropharmacological options for the treatment of essential tremor","volume":"18","author":"Alonso-Navarro","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.prdoa.2025.100381_b0205","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/postgradmedj-2019-136647","article-title":"Treatment of essential tremor: current status","volume":"96","author":"Sharma","year":"2020","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.prdoa.2025.100381_b0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5334\/tohm.682","article-title":"Treatment patterns in essential tremor: a retrospective analysis","volume":"12","author":"Shah","year":"2022","journal-title":"Tremor Other Hyperkinet. Mov. (N Y)"},{"key":"10.1016\/j.prdoa.2025.100381_b0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4137\/JCNSD.S6561","article-title":"Pharmacotherapy of essential tremor","volume":"5","author":"Hedera","year":"2013","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.prdoa.2025.100381_b0220","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.205","article-title":"Mechanisms of the gabapentinoids and \u03b1 2 \u03b4-1 calcium channel subunit in neuropathic pain","volume":"4","author":"Patel","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.prdoa.2025.100381_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040822","article-title":"Strategies to treat chronic pain and strengthen impaired descending noradrenergic inhibitory system","volume":"20","author":"Hayashida","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prdoa.2025.100381_b0230","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16064","article-title":"Treatment patterns in essential tremor: real-world evidence from a United Kingdom and France primary care database","volume":"31","author":"Antonazzo","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.prdoa.2025.100381_b0235","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/0897190007311453","article-title":"Essential tremor","volume":"20","author":"Chen","year":"2007","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.prdoa.2025.100381_b0240","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.prdoa.2025.100381_b0245","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3171\/2021.7.JNS211783","article-title":"Letter to the Editor. Clinical rating scale for tremor: a needed clarification","volume":"136","author":"Sarica","year":"2022","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.prdoa.2025.100381_b0250","series-title":"Clinical Rating Scale for Tremor","first-page":"271","author":"Fahn","year":"1993"},{"key":"10.1016\/j.prdoa.2025.100381_b0255","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.prdoa.2025.100381_b0260","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/mds.21629","article-title":"A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor","volume":"22","author":"Zesiewicz","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2025.100381_b0265","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00415-012-6628-x","article-title":"Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association","volume":"260","author":"Zappia","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.prdoa.2025.100381_b0270","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000163769.28552.CD","article-title":"Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"64","author":"Zesiewicz","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.prdoa.2025.100381_b0275","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e318236f0fd","article-title":"Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology","volume":"77","author":"Zesiewicz","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.prdoa.2025.100381_b0280","article-title":"Essential tremor","author":"Zesiewicz","year":"2015","journal-title":"BMJ Clin. Evid."},{"key":"10.1016\/j.prdoa.2025.100381_b0285","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/mds.27700","article-title":"MDS evidence-based review of treatments for essential tremor","volume":"34","author":"Ferreira","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2025.100381_b0290","unstructured":"K. Lyons, K. Ott, S. Holly, CPE\/IETF Essential Tremor in Adult Patients Guideline Pocket Guide, 2021."},{"key":"10.1016\/j.prdoa.2025.100381_b0295","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/CON.0000000000001181","article-title":"Diagnosis and treatment of essential tremor","volume":"28","author":"Wagle Shukla","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.prdoa.2025.100381_b0300","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10072-015-2380-1","article-title":"Review on clinical update of essential tremor","volume":"37","author":"Chunling","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.prdoa.2025.100381_b0305","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/WNL.0000000000004372","article-title":"Quality improvement in neurology: essential tremor quality measurement set","volume":"89","author":"Zesiewicz","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.prdoa.2025.100381_b0310","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.891446","article-title":"Essential tremor patients experience significant burden beyond tremor: a systematic literature review","volume":"13","author":"Gerbasi","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.prdoa.2025.100381_b0315","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s13311-013-0230-5","article-title":"The treatment of tremor","volume":"11","author":"Schneider","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.prdoa.2025.100381_b0320","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/mds.25264","article-title":"Multisite, double-blind, randomized, controlled study of pregabalin for essential tremor","volume":"28","author":"Zesiewicz","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2025.100381_b0325","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jns.2009.06.044","article-title":"Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial","volume":"285","author":"Ferrara","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.prdoa.2025.100381_b0330","first-page":"348","article-title":"Comparison the effects of gabapentin and propranolol in patients with essential tremor","volume":"7","author":"Afshinmajd","year":"2009","journal-title":"Curr. J. Neurol. (Iran. J. Neurol.)"},{"key":"10.1016\/j.prdoa.2025.100381_b0335","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1531-8257(200007)15:4<678::AID-MDS1012>3.0.CO;2-0","article-title":"Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial","volume":"15","author":"Ondo","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2025.100381_b0340","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archneur.56.4.475","article-title":"A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor","volume":"56","author":"Gironell","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.prdoa.2025.100381_b0345","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mds.870130315","article-title":"Double-blind controlled trial of gabapentin in essential tremor","volume":"13","author":"Pahwa","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2025.100381_b0350","unstructured":"U.K. Misra, To study the spectrum of tremors and compare safety and efficacy of propranolol versus gabapentin in essential tremor 2012, International Clinical Trials Registry Platform."},{"key":"10.1016\/j.prdoa.2025.100381_b0355","unstructured":"AEMPS, Evaluacion De Los Efectos De La Pregabalina En El Temblor Esencial: Ensayo Cl\u00ednico Cruzado, Randomizado A Doble Ciego Y Controlado Con Placebo. 2009, European Union Clinical Trials Register."}],"container-title":["Clinical Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112525000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112525000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T04:54:44Z","timestamp":1772513684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112525000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":71,"alternative-id":["S2590112525000854"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2025.100381","relation":{},"ISSN":["2590-1125"],"issn-type":[{"value":"2590-1125","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of pregabalin and gabapentin on essential tremor: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2025.100381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100381"}}